These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 16938187)

  • 1. [The functions of Toll-like receptors and their roles in liver diseases].
    Yang JT; Zhang LQ; He FC
    Zhonghua Gan Zang Bing Za Zhi; 2006 Aug; 14(8):632-4. PubMed ID: 16938187
    [No Abstract]   [Full Text] [Related]  

  • 2. Toll-like receptor signaling in the liver.
    Schwabe RF; Seki E; Brenner DA
    Gastroenterology; 2006 May; 130(6):1886-900. PubMed ID: 16697751
    [No Abstract]   [Full Text] [Related]  

  • 3. Toll-like receptors in acute liver injury and regeneration.
    Chen Y; Sun R
    Int Immunopharmacol; 2011 Oct; 11(10):1433-41. PubMed ID: 21601014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The orchestra of Toll-like receptors and their potential role in frequently occurring rheumatic conditions.
    Roelofs MF; Abdollahi-Roodsaz S; Joosten LA; van den Berg WB; Radstake TR
    Arthritis Rheum; 2008 Feb; 58(2):338-48. PubMed ID: 18240239
    [No Abstract]   [Full Text] [Related]  

  • 5. Toll-like receptors and dermatology.
    Petry V; Gaspari AA
    Int J Dermatol; 2009 Jun; 48(6):558-70. PubMed ID: 19538362
    [No Abstract]   [Full Text] [Related]  

  • 6. Toll-like receptors and adaptor molecules in liver disease: update.
    Seki E; Brenner DA
    Hepatology; 2008 Jul; 48(1):322-35. PubMed ID: 18506843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IRFs: master regulators of signalling by Toll-like receptors and cytosolic pattern-recognition receptors.
    Honda K; Taniguchi T
    Nat Rev Immunol; 2006 Sep; 6(9):644-58. PubMed ID: 16932750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nucleic acid recognizing Toll-like receptors and autoimmunity.
    von Landenberg P; Bauer S
    Curr Opin Immunol; 2007 Dec; 19(6):606-10. PubMed ID: 18060756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A notch in the toll belt.
    Hertzog P
    Immunity; 2008 Nov; 29(5):663-5. PubMed ID: 19006687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toll-like receptors, inflammation and tumor in the human female reproductive tract.
    Yu L; Wang L; Chen S
    Am J Reprod Immunol; 2009 Jul; 62(1):1-8. PubMed ID: 19527227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toll-free immunity?
    Valiante N; De Gregorio E; Rappuoli R
    Nat Med; 2008 Dec; 14(12):1318-9. PubMed ID: 19057556
    [No Abstract]   [Full Text] [Related]  

  • 12. Toll-like receptors.
    Dasari P; Nicholson IC; Zola H
    J Biol Regul Homeost Agents; 2008; 22(1):17-26. PubMed ID: 18394314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Innate immune sensing and activation of cell surface Toll-like receptors.
    Tapping RI
    Semin Immunol; 2009 Aug; 21(4):175-84. PubMed ID: 19493685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple roles of Toll-like receptor signaling in atherosclerosis.
    Björkbacka H
    Curr Opin Lipidol; 2006 Oct; 17(5):527-33. PubMed ID: 16960501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracellular toll-like receptors.
    Blasius AL; Beutler B
    Immunity; 2010 Mar; 32(3):305-15. PubMed ID: 20346772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tracking the toll of kidney disease.
    Shirali AC; Goldstein DR
    J Am Soc Nephrol; 2008 Aug; 19(8):1444-50. PubMed ID: 18579638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Localisation and trafficking of Toll-like receptors: an important mode of regulation.
    McGettrick AF; O'Neill LA
    Curr Opin Immunol; 2010 Feb; 22(1):20-7. PubMed ID: 20060278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. With a little help from my friends: modulation of phagocytosis through TLR activation.
    Tricker E; Cheng G
    Cell Res; 2008 Jul; 18(7):711-2. PubMed ID: 18596701
    [No Abstract]   [Full Text] [Related]  

  • 19. MAPPIT analysis of early Toll-like receptor signalling events.
    Ulrichts P; Tavernier J
    Immunol Lett; 2008 Mar; 116(2):141-8. PubMed ID: 18221795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammation, cancer and chemoresistance: taking advantage of the toll-like receptor signaling pathway.
    Chen R; Alvero AB; Silasi DA; Mor G
    Am J Reprod Immunol; 2007 Feb; 57(2):93-107. PubMed ID: 17217363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.